Source: https://norml.org.nz/rights/misuse-of-drugs-act-schedules-of-class-a-b-c-drugs-and-precursors/
Timestamp: 2019-11-22 00:12:30
Document Index: 207286797

Matched Legal Cases: ['art 6', 'arts 1', 'art 3', 'art 4', 'art 4', 'arts 1', 'art 6', 'art 4', 'art 5', 'arts 1', 'arts 1', 'arts 1', 'ART 7']

Misuse of Drugs Act – schedules of Class A, B, C drugs and precursors – NORML New Zealand
Class A = Misuse of Drugs Act Schedule 1.
1.The following substances, namely:
• ACETORPHINE (03-acetyl-7,8-dihydro-7 a -[1 (R)-hydroxy-1-methyl-butyl]-06-methyl-6,14-endo ethenomorphine).
• • BUFOTENINE (3-(2-dimethylaminoethyl)-5-hydroxyindole).
• CANTHARIDIN (hexahydro-3a,7a-dimethyl-4,7-epoxyisobenzofuran-1,3-dione).
• COCAINE (methyl ester of benzoylecgonine), except when contained in a Class C controlled drug:**]
• DESOMORPHINE (dihydrodeoxymorphine).
• DET (N, N-diethyltryptamine).
• • DMA (2-amino-1-(2,5-dimethoxyphenyl) propane).]
• DMHP (3-(1,2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6 H-dibenzo[b, d] pyran).
• DMT (N, N-dimethyltryptamine).
• DOB (2-amino-1-(4-bromo-2, 5-dimethoxyphenyl) propane) (also known as bromo-DMA).]
• ETORPHINE (7,8-dihydro-7 a -[1 (R)-hydroxy-1-methylbutyl]-06-methyl-6,14-endo ethenomorphine).
• HEROIN (diacetylmorphine).
• KETOBEMIDONE (4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine).
• LYSERGIC ACID (essential precursor for manufacture of LSD).]
• LYSERGIDE (N, N-diethyllysergamide or lysergic acid diethylamide).
• MDA (2-amino-1-(3,4-methylenedioxyphenyl) propane).
• MESCALINE (3,4,5-trimethoxyphenethylamine).
• METHAMPHETAMINE (2-methylamino-1-phenylpropane).]
• • 5-METHOXYDIMETHYLTRYPTAMINE (5-methoxy-N, N-dimethyl-tryptamine).
• 2-METHOXY-4, 5-METHYLENEDIOXYAMPHETAMINE (2-amino-1-(2-methoxy-4, 5-methylenedioxyphenyl) propane) (also known as MMDA or MMDA-2).]
• 3-METHOXY-4, 5-METHYLENEDIOXYAMPHETAMINE (2-amino-1-(3-methoxy-4, 5-methylenedioxyphenyl) propane) (also known as MMDA).]
• MPTP (1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine).**]
• PARAHEXYL (3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b, d] pyran).
• PCE (N-ethyl-1-phenylcyclohexylamine).]
• PCPY 1-(1-phenylcyclohexyl) pyrrolidine).***
• PHP 1-(1-phenylcyclohexyl) pyrrolidine).***
• PEPTP (1-(2-phenylethyl)-4-phenyl-1,2,5,6-tetrahydropyridine).**]
• PHENCYCLIDINE (1-(1-phenylcyclohexyl) piperidine).
• PIPERIDYL BENZILATES (N-methylpiperidyl benzilates and N-ethylpiperidyl benzilates but excluding the methobromide salts).
• PMA (2-amino-1-(4-methoxyphenyl) propane).]
• PSILOCINE (3-(2-dimethylaminoethyl)-4-hydroxyindole).
• PSILOTSIN (3-(2-dimethylaminoethyl)-4-hydroxyindole).
• PSILOCYBINE (3-(2-dimethylaminoethyl) indol-4-yl dihydrogen phosphate).
• STP,DOM (2-amino-1-(2,5-dimethoxy-4-methyl) phenylpropane).
• TCP (1-[1-(2-thienyl) cyclohexyl] piperidine).***]
• • THALIDOMIDE (a -phthalimidoglutarimide).
• TMA (2-amino-1-(3, 4, 5-trimethoxyphenyl) propane).]
2.The isomers of the substances mentioned in this Schedule whenever the existence of such isomers is possible within the specific chemical designation.
3.The esters and ethers of the substances mentioned in this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Schedule whenever the existence of such esters or ethers is possible.
4.The salts of the substances mentioned in this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Schedule.
5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Schedule.
Class B = Misuse of Drugs Act Schedule 2
[AMPHETAMINE (2-amino-1-phenylpropane).]
[CANNABIS preparations: that is, any preparation containing any tetrahydrocannabinols, including cannabis resin (commonly know as hashish) and cannabis oil (commonly known as hash oil), produced by subjecting cannabis plant material to any kind of processing.]
[MDMA (2-methylamino-1-(3,4-methylenedioxyphenyl) propane).]
2.The isomers of the substances mentioned in [clause 1 of] this Part of this Schedule whenever the existence of such isomers is possible within the specific chemical designation.
3.The esters and ethers of the substances mentioned in [clause 1 of] this Part of this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.
4.The salts of the substances mentioned in [clause 1 of] this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule.
[6.The substance gamma-hydroxybutyrate (“GHB”) (commonly known as fantasy) and—
(a)the esters, ethers, and amides of GHB; and
(b)all substances from which GHB can be derived, including (without limitation)—
(i)1,4-butanediol:
(ii)gamma-aminobutyric acid:
(iii)gamma-butyrolactone:
(iv)gamma-hydroxybutyraldehyde; and
(c)the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph (a) or paragraph (b); and
(d)any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs (a) to (c).]
[1.The following substances, namely:
FENCAMFAMINE (N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine).
4-METHYLTHIOAMPHETAMINE.]]
2.The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the specific chemical designation.
3.The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.
4.The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
[ACETYL-a-METHYLFENTANYL (N-[1-(a-methylphenethyl]-4-piperidyl] acetanilide).]
[ALFENTANIL (N -[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1 H-(tetrazol- 1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N -phenylpropanamide).*]
ALPHACETYLMETHADOL (a-3-acetoxy-6-dimethylamino-4,4-diphenylheptane).
ALPHAMEPRODINE (a-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine).
BETACETYLMETHADOL (b-3-acetoxy-6-dimethylamino-4,4-diphenylheptane).
CONCENTRATE OF POPPY STRAW—that is, the material arising when parts of any plant of the species Papaver somniferum have entered a process for the concentration of the alkaloids.
DIETHYLTHIAMBUTENE (3-diethylamino-1,1-di-(2′-thienyl)-1-butene).
DIMETHYLTHIAMBUTENE (3-dimethylamino-1,1-di-(2′-thienyl)-1-butene).
ETHYLMETHYLTHIAMBUTENE (3-ethylmethylamino-1,1-di-(2′-thienyl)-1-butene).
ETONITAZENE (1-diethylaminoethyl-2-para -ethoxybenzyl-5-nitrobenzimidazole).
FENTANYL (1-phenethyl-4-(N-propionylanilino)piperidine).
[p-FLUOROFENTANYL (4′-fluoro-N-1-(phenethyl-4-piperidyl) propionanilide).]
[b-HYDROXYFENTANYL (N-[1-(b-hydroxyphenethyl)-4-piperidyl] propionanilide).]
HYDROXYPETHIDINE (4-meta -hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester).
LEVOMETHORPHAN ((-)-3-methoxy-N-methylmorphinan) but not including dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan).
LEVOMORAMIDE ((-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl] morpholine).
LEVOPHENACYLMORPHAN ((-)-3-hydroxy-N -phenacylmorphinan).
LEVORPHANOL ((-)-3-hydroxy-N-methylmorphinan).
METAZOCINE (2′-hydroxy-2,5,9-trimethyl-6,7-benzomorphan).
METHYLDESORPHINE (6-methyl->>>>>>>>>>Unknown character &Dgr;<<<<<6-deoxymorphine).
[a-METHYLFENTANYL (N-[1-(a-methylphenethyl)-4-piperidyl] propionanilide).]
[a-METHYLTHIOFENTANYL (N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl] propionanilide).]
3-METHYLFENTANYL (N-[3-methyl-1-phenethyl-4-piperidyl] propionanilide).]
3-METHYLTHIOFENTANYL (N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide).]
NORLEVORPHANOL ((-)-3-hydroxymorphinan).
PHENADOXONE (6-morpholino-4,4diphenyl-3-heptanone).
PHENAMPROMIDE (N-(1-methyl-2-piperidinoethyl) propionanilide).
PHENAZOCINE (2′-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan).
[SUFENTANIL (N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-pipe-ridyl] propionanilide).**]
5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3 or clause 4 of this Part of this Schedule.
Class C = Misuse of Drugs Act Schedule 3.
CANNABIS PLANT [(whether fresh, dried, or otherwise)]—That is, any part of any plant of the genus Cannabis except a part from which all the resin has been extracted.
COCA LEAF—That is, the leaf of any plant of any species of the genus Erythroxylon, except a leaf from which all ecgonine, cocaine, and any other ecgonine alkaloids have been removed.
. . . . . ETHYLMORPHINE (3-ethylmorphine).
3.The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.
5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule, other than a preparation or mixture named or described in Part 6 of this Schedule.
[6.Preparations of pseudoephedrine, its salts, isomers, esters, and ethers (if any), and the salts of its isomers, esters, and ethers (if any), being preparations—
(a)in solid or liquid form; and
(b)containing not more than 60 mg of pseudoephedrine per dosage unit; and
(c)containing either a single ingredient or being in combination with other pharmacologically active ingredients, being ingredients that are not named or described in Schedule 1 or 2 or in Parts 1, 2, 4, or 5 of this schedule.]
[ALLOBARBITAL (5,5-diallylbarbituric acid).]
[BUPRENORPHINE (17-cyclopropylmethyl-7,8-dihydro-7-(1-hydroxy-1,2, 2-trimethylpropyl) -6-0-methyl-6, 14-ethano-17-normorphine).]
[SECBUTABARBITAL (5-sec-butyl-5-ethylbarbituric acid).]
5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule[, except a mixture of a derivative of barbituric acid named or described in clause 1 of this Part of this Schedule compounded with one or more other pharmacologically active ingredients not named or described in clause 1 of this Part of this Schedule].
[EPHEDRINE.]
[PSEUDOEPHEDRINE (other than a preparation referred to in clause 6 of Part 3 of this schedule).]
SPA ((-)-1-dimethylamino-1,2-diphenylethane).
[5.Mixtures of a derivative of barbituric acid named or described in Part 4 of this Schedule compounded with one or more other pharmacologically active ingredients not named or described in Part 4 of this Schedule.]
[5A.Preparations of propoxyphene, its isomers, esters, and ethers, if any, its salts, and the salts of its isomers, esters, or ethers, if any, for oral use containing not more than the equivalent of 135 milligrams of propoxyphene base per dosage unit or with a concentration of not more than 2.5 percent in undivided preparations, being preparations whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.]
[6.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, clause 4, [[clause 5 or clause 5A]] of this Part of this Schedule, other than a preparation or mixture named or described in Part 6 of this Schedule.]
(a)Preparations containing any proportion of the following substances or of any salt of any such substance, namely, acetyldihydrocodeine, codeine, dihydrocodeine, ethylmorphine, and pholcodine when:
(i)Compounded with one or more other pharmacologically active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield which would constitute a risk to health; and
(ii)Containing not more than 100 milligrams of the substance in each dosage unit and with a concentration of not more than 2.5 percent in undivided preparations:
[(aa)Preparations containing a derivative of barbituric acid named or described in Part 4 or Part 5 of this Schedule, in solutions containing not more than 0.5 percent of that derivative of barbituric acid:]
(b)Preparations of cocaine containing not more than 0.1 percent of cocaine base, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:
(c)Preparations of difenoxin containing, per dosage unit, not more than 0.5mg of difenoxin and a quantity of atropine sulphate equivalent to at least 5 percent of the dose of difenoxin:
(d)Preparations of opium or morphine containing not more than 0.2 percent of morphine, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the opium or the morphine, as the case may be, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:
(e)Single dosage units of diphenoxylate containing in each unit not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 25 micrograms of atropine sulphate:
(f)Liquid preparations of diphenoxylate containing, in each millilitre, not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atroprine sulphate:
[(ff)Preparations of propiram containing not more than 100 mg of propiram per dosage unit and compounded with at least the same amount of methylcellulose:]
(g)Ipecacuanha and opium powder containing 10 percent of opium in powder and 10 percent of ipecacuanha root in powder intimately mixed with finely powdered lactose:
(h)Mixtures containing not more than one of the preparations specified in paragraphs (a) to (g) of this Part of this Schedule, being mixtures whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.
[PART 7
AMPHETAMINE ANALOGUES, in which the 1-amino-2-phenylethane nucleus carries any of the following radicals, either alone or in combination:
(a)An alkyl radical, with up to 6 carbon atoms, attached to the nitrogen atom:
(b)A phenalkyl radical, with up to 12 carbon atoms, attached to the nitrogen atom:
(c)A phenalkyl radical, as in paragraph (b), with 1 or more alkyl radicals, each with up to 6 carbon atoms, attached to the benzene ring in the phenalkyl radical:
(d)An alkylcarbonyloxy or alkoxycarbonyl or hydroxy radical, with up to 6 carbon atoms, attached to the 4 position in the piperidine ring:
(e)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.
(a)The alkylamino radical is 1-piperidinyl, 1-pyrrolidinyl, 4-morpholinyl, or any other radical with up to 6 carbon atoms in the alkyl portion:
(b)The aryl radical is phenyl, thienyl, pyridinyl, or pyrrolidinyl:
(c)The aryl radical, as described in paragraph (b), carries any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals.
FENTANYL ANALOGUES, in which the N-[1-(2-phenethyl)-4-piperidyl]aniline nucleus has additional radicals, either alone or in combination, attached as follows:
(a)An acetyl, propionyl, butenoyl or butanoyl radical, attached to the aniline nitrogen atom:
(b)One or more alkyl radicals, with up to 10 carbon atoms in total, attached to the ethyl moeity:
(c)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) [[and/or halogen radicals,]] attached to each of the benzene rings.
(a)An alkyl radical, with up to 6 carbon atoms, attached at the two position:
(b)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the aryl rings.
(a)1 or 2 alkyl radicals, each with up to 6 carbon atoms, including cyclic radicals, attached to the amino nitrogen atom:
(b)1 or 2 methyl groups, or an ethyl group, attached to the carbon atom adjacent to the amino nitrogen atom:
(c)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.]